Connection
James Marsh to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications James Marsh has written about Platelet Aggregation Inhibitors.
|
|
Connection Strength |
|
|
|
|
|
0.970 |
|
|
|
-
Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD. Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department. Vasc Health Risk Manag. 2013; 9:187-93.
Score: 0.391
-
Sharma RK, Voelker DJ, Sharma R, Reddy HK, Dod H, Marsh JD. Evolving role of platelet function testing in coronary artery interventions. Vasc Health Risk Manag. 2012; 8:65-75.
Score: 0.359
-
Marsh JD. Early use of glycoprotein IIb/IIIa-receptor inhibitors in non-ST-segment-elevation acute coronary syndromes. Am J Health Syst Pharm. 2002 Nov 01; 59(21 Suppl 7):S15-26.
Score: 0.189
-
Lowery CL, Elliott C, Cooper A, Hadden C, Sonon RN, Azadi P, Williams DK, Marsh JD, Woulfe DS, Kilic F. Cigarette Smoking-Associated Alterations in Serotonin/Adrenalin Signaling Pathways of Platelets. J Am Heart Assoc. 2017 May 18; 6(5).
Score: 0.032